VS
Harvest Healthcare Leaders Income ETF (HHL) and BMO SPDR Health Care Select Sector Index ETF (ZXLV) offer distinct profiles for Canadian ETF investors. A direct comparison shows that HHL focuses its top 3 sector exposures on Healthcare and Sovereign, while ZXLV leans towards Healthcare and Consumer Non-Cyclicals. When evaluating costs, HHL features a management fee (MER) of 0.85%, compared to 0.21% for ZXLV. Performance-wise, HHL has returned 0.32% year-to-date with +$354 M in net flows, whereas ZXLV is at 9.03% with +$24 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
HHL
ZXLV
| AuM | $1,833.20 M | $39.97 M |
| Management Fees | 0.85% | 0.21% |
| Exp. ratio | 0.98% | 0.21% |
| Tracking Difference | - | - |
Historical performance and flows
As of September 9, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | HHL | -3.52% | +4.74% | -0.32% | +8.86% | +18.71% |
ZXLV | -2.03% | +7.09% | +9.03% | +21.47% | - | |
| Flows | HHL | -$1 M | +$41 M | +$354 M | +$356 M | +$688 M |
ZXLV | -$5 M | +$17 M | +$24 M | +$35 M | - |
HHL vs ZXLV exposure
Countries
HHL
USA
84.21%
Other
15.79%
ZXLV
USA
97.53%
Sectors
HHL
Healthcare
98.89%
ZXLV
Healthcare
97.51%
As of September 9, 2026
Top 10 Holdings
HHL
Regeneron Pharmaceuticals, Inc.
5.34%
Boston Scientific Corp.
5.14%
Bristol Myers Squibb Co.
5.10%
Thermo Fisher Scientific, Inc.
5.00%
Merck & Co., Inc.
4.99%
Elevance Health, Inc.
4.99%
Amgen, Inc.
4.95%
Agilent Technologies, Inc.
4.95%
Intuitive Surgical, Inc.
4.94%
UnitedHealth Group, Inc.
4.94%
ZXLV
Eli Lilly & Co.
15.48%
Johnson & Johnson
10.51%
AbbVie, Inc.
7.55%
UnitedHealth Group, Inc.
6.41%
Merck & Co., Inc.
5.48%
Thermo Fisher Scientific, Inc.
3.64%
Amgen, Inc.
3.54%
Abbott Laboratories
3.14%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.43%
Diversification
HHL
Total weight of top 10 holdings out of 25 total
50.34%
ZXLV
Total weight of top 10 holdings out of 59 total
60.94%
Characteristics
Compare
HHL
ZXLV
| Provider | Harvest Portfolios Group | BMO |
| Management | Actively managed | Passively managed |
| Benchmark | - | S&P Health Care Select Sector Total Return Index - USD |
| Replication Method | ||
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 10.03% | 0.46% |
| Meets ESG criteria | No | No |
| Inception Date | December 18, 2014 | February 2, 2025 |
Frequently asked questions about HHL and ZXLV
Which ETF has performed better year to date: HHL or ZXLV?
As of September 9, 2026, HHL has returned -0.32% year to date, while ZXLV has returned 9.03%. ZXLV is ahead on YTD performance.
Which ETF is larger by assets under management: HHL or ZXLV?
As of September 9, 2026, HHL manages $1.83 B in assets, while ZXLV manages $39.97 M. HHL is the larger fund by AUM.
How are HHL and ZXLV managed?
HHL is actively managed by Harvest Portfolios Group. It does not track an index. ZXLV is passively managed by BMO. It tracks the S&P Health Care Select Sector Total Return Index - USD benchmark.
What sectors do HHL and ZXLV emphasize?
HHL is most exposed to Healthcare and Sovereign. ZXLV is most exposed to Healthcare and Consumer Non-Cyclicals.
Which ETF is attracting more investor flows: HHL or ZXLV?
Year to date, HHL has seen +$354.17 M in net flows, compared with +$23.63 M for ZXLV. HHL has attracted more net investor money so far.
How do the fees of HHL and ZXLV compare?
HHL has an expense ratio of 0.98%, while ZXLV has an expense ratio of 0.21%.
What are the top holdings of HHL and ZXLV?
HHL's largest holdings include Regeneron Pharmaceuticals, Inc., Boston Scientific Corp., and Bristol Myers Squibb Co.. ZXLV's top holdings include Eli Lilly & Co., Johnson & Johnson, and AbbVie, Inc..
Which ETF is more diversified: HHL or ZXLV?
HHL holds 25 securities, while ZXLV holds 59. On holdings count, ZXLV is the more diversified portfolio.
Recent articles about HHL and ZXLV
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.